Lasa Supergenerics Ltd share price logo

Lasa Supergenerics Ltd Share Price (LASA)

₹9.752.89%

as on

| Source : NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Lasa Supergenerics Ltd Stock Performance

as on August 14, 2025 at 4:01 PM IST

  • Day's Low

    Day's High

    ₹9.61
    ₹10
    downward going graph

    1.44%

    Downside

    2.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹8.42
    ₹33.49
    downward going graph

    13.64%

    Downside

    243.49%

    Upside

    downward going graph
Previous Close₹10.04
Open₹10.00
Volume40.94K
Upper Circuit₹10.54
Lower Circuit₹9.53
Day's Low9.61
Day's High10
52 Week Low8.42
52 Week High33.49
1 Month Return-18.07 %
3 Month Return-47.21 %
1 Year Return-60.97 %
3 Year Return-70.41 %
5 Year Return-83.36 %

Lasa Supergenerics Ltd Stock Fundamentals & Key Indicators

Check Lasa Supergenerics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹48.85 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

0

Return on capital employed (ROCE)

0

Beta (LTM)

0.81

P/B Ratio

1.14

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

673.63

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Lasa Supergenerics Ltd Stock's Interest Amongst Investors

-47%

Period Aug 17, 2025 to Jul 18, 2025. Change in 30 Days vs previous period

Search interest for Lasa Supergenerics Ltd Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Lasa Supergenerics Ltd Financial Results

Get the annual and quarterly financial summary of Lasa Supergenerics Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26
Revenue

(in ₹ Cr)

31 (0%)39 (28%)33 (16%)39 (18%)20 (49%)
Net Income

(in ₹ Cr)

-3 (0%)-3 (18%)5 (270%)-14 (360%)-21 (48%)
Net Profit Margin-8.85% (0%)-8.20% (7%)16.60% (302%)-36.51% (320%)-105.55% (189%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

208 (0%)209 (1%)164 (22%)151 (8%)
Total Liabilities

(in ₹ Cr)

49 (0%)52 (5%)46 (11%)55 (19%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

14 (0%)41 (203%)9 (78%)-17 (288%)2 (112%)

Lasa Supergenerics Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Lasa Supergenerics Ltd.

  • Lasa Supergenerics Ltd Earnings Results

    Lasa Supergenerics Ltd’s net profit fell -673.63% since last year same period to ₹-21.12Cr in the Q1 2025-2026. On a quarterly growth basis, Lasa Supergenerics Ltd has generated -47.8% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Lasa Supergenerics Ltd Dividends April,2022

    In the quarter ending March 2022, Lasa Supergenerics Ltd has declared dividend of ₹0.25 per share on 11 Apr 2022 - translating a dividend yield of 5.13%.

    Read More about Dividends

Lasa Supergenerics Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Lasa Supergenerics Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
53.65%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
46.35%
0.00
Others
0%
0.00

Lasa Supergenerics Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Lasa Supergenerics Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA48.85-16.67%0.00-22104
NA138.38-10.52%0.001269
NA48.17105.43%0.00-1NA
NA496.3321.03%0.00NANA
NA4.498.31%0.00-1NA

Lasa Supergenerics Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Lasa Supergenerics Ltd.

  • Lasa Supergenerics Promoter Maintains Shareholding Stability - 20 Apr, 2025

    Lasa Supergenerics Ltd. announced that promoter Omkar Herlekar has not made any new encumbrance of shares for the financial year ending March 31, 2025, ensuring stability and transparency in shareholding patterns.

Insights on Lasa Supergenerics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.65% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 32.3% return, outperforming this stock by 93.3%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 46.35% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 130.2% return, outperforming this stock by 200.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LASA stock has moved down by -7.8%

About Lasa Supergenerics Ltd

Lasa Supergenerics Limited is a vertically integrated manufacturer of veterinary, animal and human healthcare products, based in India. The company produces API pharmaceuticals, drugs, and chemicals, and was established in March 2016. It has a large manufacturing facility at Mahad Chiplun, Maharashtra, specializing in catalyst chemistry and manufacturing anthelmintic/veterinary API products. Lasa Supergenerics produces products with the highest production capabilities in India, with their products being available in multiple countries. They recently launched two new 'blockbuster products' with the strong segment of Oxycozanide, being the main one. Oxyclozanide is an anthelmintic used in the treatment and control of fascioliasis and with huge global demand for the product, the company is confident of grabbing significant market share. The products are all manufactured in accordance with Good Manufacturing Practice (GMP) and world-class technology. The leadership team is well-positioned to lead the company into the future and the company is committed to becoming a leading force in animal healthcare solutions.

Revenue: ₹20.01Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-21.12Cr as on June 2025 (Q1 FY26)
Listing date: 21 Sep, 2017
Chairperson Name: Omkar P Herlekar
OrganisationLasa Supergenerics Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOOmkar P Herlekar
E-voting on sharesClick here to vote

FAQs

What is Lasa Supergenerics Ltd share price today?

Lasa Supergenerics Ltd share price today stands at ₹9.75, Open: ₹10, Previous Close: ₹10.04, High: ₹10, Low: ₹9.61, 52 Week High: ₹33.49, 52 Week Low: ₹8.42 as on .

How to buy Lasa Supergenerics Ltd shares ?

To buy Lasa Supergenerics Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LASA or Lasa Supergenerics Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Lasa Supergenerics Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Lasa Supergenerics Ltd?

Today's traded volume of Lasa Supergenerics Ltd is 40.94K. Which means that 40.94K shares of Lasa Supergenerics Ltd were bought and sold on the stock market during today's trading session.

What is Lasa Supergenerics Ltd's market cap today?

Today's market capitalisation of Lasa Supergenerics Ltd is ₹48.85 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Lasa Supergenerics Ltd?

Lasa Supergenerics Ltd’s 52 week high is ₹33.49 and 52 week low is ₹8.42. The current share price of Lasa Supergenerics Ltd is ₹9.75, which is -70.89% down from its 52 week high and 15.80% up from its 52 week low.